Patents Owned by the CDC
Most Americans believe that government agencies are untainted by corporate interest and working to benefit the people who pay their salaries and are pledged to serve.
From the CDC.gov website:
The Centers for Disease Control and Prevention (CDC) serves as the national focus for developing and applying disease prevention and control, environmental health, and health promotion and health education activities designed to improve the health of the people of the United States.
What would you say in the face of absolute proof that the CDC is not only tainted by corporate interest, but by big pharmaceutical donors and lucrative personal profit streams? In fact the only ones who do not have a say in what the CDC decides is safe for public use, how often and when to take its products, or how it designates “health emergencies,” are the people it is supposed to serve and anything that contradicts what BIG PHARMA wants.
It’s one thing to speak about profit streams and collusion while it’s quite another to prove them. SPEAK Project has gone to great lengths to uncover patents, contracts, and money trails in order to bring you proof that your government agencies are not who they say they are.

Other Patents Owned by the CDC
-
Nucleic acid vaccines for prevention of flavivirus infection
has applications in vaccines for Zika, West Nile virus, Dengue fever, tick-borne encephalitis virus, yellow fever, Palm Creek virus, and Parramatta River virus
-
AEROSOL DELIVERY SYSTEMS AND METHODS
There are several patents for administering various ”shots” via aerosol delivery systems for vaccines.
-
Viral protein quantification process and vaccine quality control therewith
The invention has utility in quantifying proteins in a complex preparation of uni- or multivalent commercial or research vaccine preparations.
-
RETROVIRUS AND RELATED METHOD USED FOR PRODUCING A MODEL FOR EVALUATING THE ANTIRETROVIRAL EFFECTS OF DRUGS AND VACCINES
This patent is used in producing a model for evaluating the antiretroviral effects of drugs and vaccines.
-
METHODS AND COMPOSITIONS FOR AN ARTIFICIAL LUNG ORGAN CULTURE SYSTEM
Bioreactors or fermenters specially adapted for specific uses for producing artificial tissue or for ex-vivo cultivation of tissue.
Other Patents Owned by the CDC
-
METHOD FOR DETECTION OF ANTIGEN-SPECIFIC ANTIBODIES IN BIOLOGICAL SAMPLES
The assay allows for the detection of antigen-specific antibodies in any species, including species for which secondary antibodies or antisera have not been developed or are not available.
-
MODULATION OF REPLICATIVE FITNESS BY DEOPTIMIZATION OF SYNONYMOUS CODONS
Methods of producing a pathogen with reduced replicative fitness are disclosed, as are attenuated pathogens produced using the methods.
-
CD40 LIGAND ADJUVANT FOR RESPIRATORY SYNCYTIAL VIRUS
This patent provides methods and adjuvants for enhancing an immune response to RSV in a host, wherein the methods and adjuvants comprise a source of a CD40 binding protein.
-
COMPOSITIONS AND METHODS FOR DETECTING ADULT TAENIA SOLIUM
The polypeptides are useful as diagnostic agents for the detection of adult tapeworm infection.
-
SELECTIVE DETECTION OF HUMAN RHINOVIRUS
A process for detecting human rhinovirus nucleic acid in a biological sample. A kit is provided for detecting and quantifying human rhinovirus in a biological sample.
Share this:
- Click to share on Pocket (Opens in new window)
- Click to share on LinkedIn (Opens in new window)
- Click to share on Skype (Opens in new window)
- Click to share on WhatsApp (Opens in new window)
- Click to share on Telegram (Opens in new window)
- Click to share on Reddit (Opens in new window)
- Click to share on Pinterest (Opens in new window)
- Click to share on Tumblr (Opens in new window)
- Click to print (Opens in new window)